Invention Grant
- Patent Title: Fused indane compound
- Patent Title (中): 稠油茚满化合物
-
Application No.: US12741307Application Date: 2008-11-26
-
Publication No.: US08211907B2Publication Date: 2012-07-03
- Inventor: Satoshi Hayashibe , Shingo Yamasaki , Nobuyuki Shiraishi , Hiroaki Hoshii , Takahiko Tobe
- Applicant: Satoshi Hayashibe , Shingo Yamasaki , Nobuyuki Shiraishi , Hiroaki Hoshii , Takahiko Tobe
- Applicant Address: JP Tokyo
- Assignee: Astellas Pharma Inc.
- Current Assignee: Astellas Pharma Inc.
- Current Assignee Address: JP Tokyo
- Agency: Fitzpatrick, Cella, Harper & Scinto
- Priority: JP2007-307753 20071128
- International Application: PCT/JP2008/071370 WO 20081126
- International Announcement: WO2009/069610 WO 20090604
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D221/06
Abstract:
To provide a compound which is useful as an NMDA receptor antagonist. The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like.
Public/Granted literature
- US20100267695A1 FUSED INDANE COMPOUND Public/Granted day:2010-10-21
Information query
